Edgewise Therapeutics, Inc. EWTX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Edgewise Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,015,711 | $108.3M | 5.66% |
| CITADEL ADVISORS LLC | 530,807 | $21.6M | 0.5% |
| D. E. Shaw & Co., Inc. | 189,115 | $7.7M | 0.18% |
| Point72 Asset Management, L.P. | 131,862 | $5.4M | 0.12% |
| TWO SIGMA INVESTMENTS, LP | 49,548 | $2.0M | 0.05% |
| AQR CAPITAL MANAGEMENT LLC | 18,456 | $749,869 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.